Prevalence, relegation or resurruction: the future of single interfering RNA and antisense oligonucleotide APIs.

Prevalence, relegation or resurruction: the future of single interfering RNA and antisense oligonucleotide APIs.

Not applicable

Bibliographic Details
Main Author:	Shireesh P Apte
Format:	Article
Language:	English
Published:	International Pharmaceutical Excipients Council 2022-09-01
Series:	Journal of Excipients and Food Chemicals
Online Access:	https://jefc.scholasticahq.com/article/38658-prevalence-relegation-or-resurruction-the-future-of-single-interfering-rna-and-antisense-oligonucleotide-apis

Similar Items

Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
by: Clarice Gareri, et al.
Published: (2022-07-01)

Lp(a) in the Pathogenesis of Aortic Stenosis and Approach to Therapy with Antisense Oligonucleotides or Short Interfering RNA
by: Assunta Di Costanzo, et al.
Published: (2023-10-01)

Wrangling RNA: Antisense oligonucleotides for neurological disorders
by: Talbot, K, et al.
Published: (2019)

Discovering antisense reagents by hybridization of RNA to oligonucleotide arrays.
by: Southern, E, et al.
Published: (1997)

Excipient-API interactions in dry powder inhalers
by: Shireesh Apte
Published: (2016-11-01)

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
by: Sarah Bajan, et al.
Published: (2020-01-01)

Selective targeting of MYC mRNA by stabilized antisense oligonucleotides
by: Gill, Taylor, et al.
Published: (2024)

Peptide-mediated cell and in vivo delivery of antisense oligonucleotides and siRNA
by: Järver, P, et al.
Published: (2012)

Correction: A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides.
by: Dorota Magner, et al.
Published: (2016-01-01)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
by: Saumya Jani, et al.
Published: (2021-04-01)

In-silico study of antisense oligonucleotide antibiotics
by: Erica S. Chen, et al.
Published: (2023-11-01)

Antisense Oligonucleotides: Concepts and Pharmaceutical Applications
by: Ariana Araya, et al.
Published: (2023-02-01)

Towards understanding and applications of antisense oligonucleotides
by: Nguyen, Le Tuan Anh
Published: (2020)

Selective targeting of MYC by antisense oligonucleotides
by: Gill, Taylor Elizabeth
Published: (2018)

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
by: Peter Järver, et al.
Published: (2012-01-01)

Thermodynamics and kinetics of antisense oligonucleotide hybridization to a structured mRNA target
by: Walton, S. Patrick (Stephen Patrick), 1973-
Published: (2008)

Nonviral delivery systems for antisense oligonucleotide therapeutics
by: Si Huang, et al.
Published: (2022-09-01)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
by: Maria Gagliardi, et al.
Published: (2021-04-01)

Antisense Oligonucleotide-Based Therapy of Viral Infections
by: Woan-Yuh Tarn, et al.
Published: (2021-11-01)

Antisense oligonucleotide therapy for KCNT1 encephalopathy
by: Lisseth Estefania Burbano, et al.
Published: (2022-12-01)

Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish.
by: Andrea Pauli, et al.
Published: (2015-01-01)

Antisense oligonucleotides: the next frontier for treatment of neurological disorders
by: Rinaldi, C, et al.
Published: (2017)

Selecting effective antisense reagents on combinatorial oligonucleotide arrays.
by: Milner, N, et al.
Published: (1997)

Optimizing tissue-specific antisense oligonucleotide-peptide conjugates.
by: Betts, C, et al.
Published: (2012)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

The Evolution of Antisense Oligonucleotide Chemistry—A Personal Journey
by: Sudhir Agrawal
Published: (2021-05-01)

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
by: Karishma Dhuri, et al.
Published: (2020-06-01)

Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
by: Valentina Giudice, et al.
Published: (2020-05-01)

Antisense oligonucleotides: a novel Frontier in pharmacological strategy
by: D. Collotta, et al.
Published: (2023-11-01)

Antisense oligonucleotide is a promising intervention for liver diseases
by: Kailing Lu, et al.
Published: (2022-12-01)

Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice
by: Karah Nazor Friberg, et al.
Published: (2012-01-01)

Quantitative fluorescence imaging of antisense oligonucleotide mediated knockdown
by: Chan, Nicholas Zhen Woon
Published: (2024)

Engineering antisense oligonucleotides as a tool in synthetic biology.
by: Chng, Si Hui.
Published: (2013)

OPTIMIZING THE DESIGN OF ANTISENSE THERAPEUTICS USING OLIGONUCLEOTIDE ARRAYS
by: Casegreen, S, et al.
Published: (1994)

Progress in the Treatment of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
by: XU Tingting, et al.
Published: (2022-04-01)

PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.
by: shireesh apte
Published: (2018-03-01)

Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
by: Kole Ryszard, et al.
Published: (2011-10-01)

Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin
by: Monique C. P. Mendonça, et al.
Published: (2023-02-01)

Naming and the Relegation of Poor Migrants: an Ubuntu Appraisal
by: Rudolph Nyamudo
Published: (2022-11-01)

Transformation of the Institute of the Criminal Case Relegation to the Prosecutor
by: O. A. Voltornist
Published: (2014-12-01)